Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05488795 · ClinicalTrials.gov registry record · NA
Team-Based Home Blood Pressure Monitoring
A NA study of Hypertension and High Blood Pressure, sponsored by University of Rochester.
- Active
- Registry status
- NA
- Development phase
- 5,760
- Enrollment target
- 1
- Study location
NCT05488795 is a NA study of Hypertension and High Blood Pressure that is active but no longer recruiting, run by University of Rochester. The registered enrollment target is 5,760 participants, above the 3,495-participant average among 470 other Hypertension trials with a reported enrollment target (65% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05488795, a NA study of Hypertension and High Blood Pressure, is active but no longer recruiting, sponsored by University of Rochester.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 5,760 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall goal of this study is to identify and rigorously evaluate strategies for implementing and sustaining team-based home blood pressure monitoring (TB-HBPM) within primary care. The TB-HBPM intervention is a multifaceted program involving patient transmission of blood readings to EHR and clinical decision support. Implementation strategies include group-based education on hypertension measurement, target blood pressure goals, drug and lifestyle management, referral to community resources, and team training designed to optimize the coordination of hypertension care, and monthly audit and feedback reports to teams and clinicians. Hypertension control rates are suboptimal in many primary care practices with persistent racial disparities in control. Team-based home blood pressure monitoring (TB-HPBM) involving patient transmission of their home blood pressure readings in real-time to their clinical team has been shown to improve blood pressure control. There is an urgent need to implement TB-HBPM into practice. The overall objective of this research is to assess implementation strategies that mitigate barriers and leverage facilitators to TB-HBHM on hypertension control and disparities between Black and White patients. The study team and investigators will use mixed methods to assess the process and generate knowledge to facilitate broader uptake of TB-HBPM.
Conditions Studied
Interventions
- BEHAVIORAL Team-Based Home Blood Pressure Monitoring
Study Locations (1)
New York
- Highland Family Medicine - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,760 participants |
| Start Date | 2022-10-01 |
| Est. Completion | 2026-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05488795
The ClinicalTrials.gov registry entry for NCT05488795 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 5,760 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 3,495-participant average among 470 other Hypertension trials with a reported enrollment target (65% higher). The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Team-Based Home Blood Pressure Monitoring is the first listed.
NCT05488795 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT05488795 about?
NCT05488795 is a clinical study titled "Team-Based Home Blood Pressure Monitoring". The overall goal of this study is to identify and rigorously evaluate strategies for implementing and sustaining team-based home blood pressure monitoring (TB-HBPM) within primary care. The TB-HBPM intervention is a multifaceted program involving patient transmission of blood readings to EHR and cl...
What is the current status of trial NCT05488795?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 5,760 participants. The study started on 2022-10-01. Estimated completion is 2026-08-31.
What conditions does trial NCT05488795 study?
This clinical trial studies the following conditions: Hypertension, High Blood Pressure.
What interventions are being tested in trial NCT05488795?
The interventions under investigation include: Team-Based Home Blood Pressure Monitoring (BEHAVIORAL).
Who is sponsoring clinical trial NCT05488795?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05488795 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes
RECRUITING · NA
-
Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Early Time-Restricted Eating in Older Adults With Hypertension
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.